Advisory Research’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-7,855
Closed -$550K 394
2019
Q1
$550K Sell
7,855
-7,171
-48% -$532K 0.01% 284
2018
Q4
$968K Buy
+15,026
New +$1.05M 0.02% 238

Other funds holding GHDX

Advisory Research's GHDX Position: Q2 2019 in Review

Advisory Research sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 7,855 shares — an estimated $550K sold.

Advisory Research first reported a position in GHDX in Q4 2018 and held it in 2 quarters. The position peaked at $968K in Q4 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Advisory Research reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Advisory Research sold 7,855 Genomic Health, Inc. shares in Q2 2019, an estimated $550K.
  • Advisory Research first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 2 quarters.
  • Advisory Research's Genomic Health, Inc. position peaked at $968K in Q4 2018.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Advisory Research's 13F filing for Q2 2019, filed 14 Aug 2019.